CP21R7 is an effective and specific GSK3β inhibitor. It is used as an activator of stem cells prior to the induction of differentiation of stem cells to smooth muscle and endothelial cells. CP21R7 can be combined with BMP4 to commit human pluripotent stem cells to a mesodermal fate.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 89 | |
2 mg | In stock | $ 160 | |
4 mg | In stock | $ 240 | |
10 mg | In stock | $ 467 | |
20 mg | In stock | $ 709 |
Description | CP21R7 is an effective and specific GSK3β inhibitor. It is used as an activator of stem cells prior to the induction of differentiation of stem cells to smooth muscle and endothelial cells. CP21R7 can be combined with BMP4 to commit human pluripotent stem cells to a mesodermal fate. |
Targets&IC50 | PKCα:1900 nM., GSK-3β:1.8 nM |
Synonyms | CP21 |
CAS No. | 125314-13-8 |
Chemical Formula | C19H15N3O2 |
Molecular Weight | 317.348 |
Solubility | Ethanol: 1 mg/mL (3.15 mM) DMSO: 59 mg/mL (185.9 mM); H2O: <1 mg/mL |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom